![](https://netrf.org/wp-content/uploads/2017/10/carl-june-300x245.jpg)
CAR T-Cell Therapy Earns Another FDA Approval
He is a pioneer whose work has helped extend the horizon of cancer care, creating a new category of individualized immunotherapy. Carl June, MD, has conducted 25 years of scientific research to advance CAR T-cell therapy. And all that knowledge is now helping to tackle NETs.